Foxhall Research Center

Washington D.C., District of Columbia 20016

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) — Completed
• An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis — Stopped early